CVS · trading date Oct 13, 2026 · previous close $87.76 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$402.07B
Net income
$1.77B
Total assets
$253.54B
Total liabilities
$178.16B
Stockholders' equity
$75.21B
Cash & equivalents
$8.45B
Operating income
$4.66B
Operating cash flow
$10.64B
Capital expenditures
$2.83B
Fiscal year 2025, via 10-K filed 2026-02-10.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
1.2%
Net margin
0.4%
Free cash flow
$7.81B
Free cash flow margin
1.9%
Liabilities / assets
70.3%
Equity / assets
29.7%
CapEx / revenue
0.7%
Operating cash flow / net income
6.02×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Woonsocket, RI 02895
ONE CVS DR.
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:53 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.